# Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study

> **NCT04804137** · — · COMPLETED · sponsor: **University Hospital, Tours** · enrollment: 24 (actual)

## Conditions studied

- Non-squamous Lung Cancer
- Metastatic Lung Cancer

## Interventions

- **OTHER:** Blood
- **OTHER:** sputum
- **OTHER:** saliva
- **OTHER:** stool

## Key facts

- **NCT ID:** NCT04804137
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-03
- **Primary completion:** 2022-09-26
- **Final completion:** 2023-07-31
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-01-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04804137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04804137, "Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04804137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*